On the one hand, CXCR3 ligands can effectively inhibit lymphangiogenesis and serve as anti-tumor agents33, while, on the other hand, high CXCR3 expression is associated with lymph node invasion and poor prognosis. This evidence concerns the gene CXCR3 and neoplasm.